The FDA is set to ban Juul Labs e-cigarettes in the US, according to reports from The Wall Street Journal, but the question is why?

The publication reported the Food and Drug Administration is preparing to order Juul Labs Inc. to take its e-cigarettes off the U.S. market following a two-year review and report in 2021 which led to the organisation banning the sale of hundreds of thousands of vaping and electronic cigarette products.

Why could Juul be banned?

In 2020, the FDA required all e-cigarette and vaping companies to submit applications to continue marketing products. The agency also banned fruit- and mint-flavoured juice pods used in e-cigarettes and vaping products, a ban that did not apply to menthol and tobacco-flavoured products.

Photo by Mario Tama/Getty Images

Then, in 2021, the FDA released the findings from a report which estimated that more than 2 million U.S. middle and high school students reported using e-cigarettes. The report also showed more than 8 in 10 of those young people were using flavoured vapes. Juul was one of the brands reported to be used by young people.

This report led to the FDA banning the sales of hundreds of thousands of vaping products but it did not rule on Juul, which came under fire for its appeal to youth vapers.

Stranger Things 4 | Volume 2 Trailer | Netflix

The Centers for Disease Control (CDC) and Prevention have also stated in the past that nicotine exposure from vaping products can ‘harm brain development in young adults’. 

Now the FDA is potentially going to ban the sale of Juul products after rejecting the company’s application to sell menthol- and tobacco-flavoured products, according to the WSJ.

Ban is ‘Long overdue’

Erika Sward, the American Lung Association’s national assistant vice president of advocacy, said the potential for the FDA to ban the sale of Juul products is ‘long overdue’, in a statement to USA Today, she also blamed the company for its ‘role’ in the ‘youth vaping epidemic’.

She said: “Juul is largely responsible for the youth vaping epidemic. No company and no product that has such blatant disregard for the health of our children and public health should be allowed to remain on the market.”

The publication also reported Theodore Wagener, director of the Center for Tobacco Research and co-leader of the Cancer Control Program at the Ohio State University Comprehensive Cancer Center, thought the FDA will ‘likely determine’ the company may not have provided ‘enough evidence to show that their product is still not appealing to youth’.

In other news, Meryl Streep was once told she was 'too ugly' to be an actress